申请人:Zhang Don
公开号:US20050148554A1
公开(公告)日:2005-07-07
The invention encompasses novel compounds of Formula I, which are anti-inflammatory and anti-thrombotic agents.
The invention also encompasses certain pharmaceutical compositions and methods for treatment of cyclooxygenases (COX-1 and COX-2) mediated diseases comprising the use of compounds of Formula I. The above compounds may be used as a combination therapy with low-dose aspirin, NSAIDs, or selective COX-2 inhibitors to treat chronic cyclooxygenases mediated diseases or conditions while simultaneously reducing the risk of thrombotic cardiovascular events.
本发明涵盖了式I的新化合物,它们是抗炎和抗血栓剂。本发明还涵盖了某些药物组合和治疗环氧合酶(COX-1和COX-2)介导疾病的方法,包括使用式I的化合物。上述化合物可以与低剂量阿司匹林、NSAIDs或选择性COX-2抑制剂一起使用,以治疗慢性COX介导的疾病或病况,同时降低血栓性心血管事件的风险。